Literature DB >> 21718328

PET and PET/CT in cardiovascular disease.

Oliver Gaemperli1, Philipp A Kaufmann.   

Abstract

The present review provides an overview of the role of cardiac positron emission tomography in the diagnosis and management of cardiovascular disease. It expands on the relative advantages and disadvantages over other imaging modalities as well as the available evidence supporting its value in the diagnosis and management of patients with coronary artery disease, the assessment of myocardial viability, and evaluation of the cardiac sympathetic nervous system. Furthermore, the recent developments, such as the implementation of high-end computed tomography devices to form hybrid systems, and the advances of molecular imaging probes in experimental applications are briefly discussed.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2011        PMID: 21718328     DOI: 10.1111/j.1749-6632.2011.06030.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

Review 1.  PET/MRI: current state of the art and future potential for cardiovascular applications.

Authors:  Nebiyu Adenaw; Michael Salerno
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

Review 2.  Cardiovascular positron emission tomography: established and emerging role in cardiovascular diseases.

Authors:  Amit Bansal; Karthikeyan Ananthasubramaniam
Journal:  Heart Fail Rev       Date:  2022-09-21       Impact factor: 4.654

Review 3.  Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation.

Authors:  Caitlund Q Davidson; Christopher P Phenix; T C Tai; Neelam Khaper; Simon J Lees
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-06-05

Review 4.  New insights from major prospective cohort studies with cardiac nuclear imaging.

Authors:  Oliver Gaemperli
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

5.  Gated F-18 FDG PET for assessment of left ventricular volumes and ejection fraction using QGS and 4D-MSPECT in patients with heart failure: a comparison with cardiac MRI.

Authors:  Yan Li; Li Wang; Shi-Hua Zhao; Zuo-Xiang He; Dao-Yu Wang; Feng Guo; Wei Fang; Min-Fu Yang
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

6.  Diagnostic value of (18)F-FDG PET in the assessment of myocardial viability in coronary artery disease: A comparative study with (99m)Tc SPECT and echocardiography.

Authors:  Mansour Al Moudi; Zhong-Hua Sun
Journal:  J Geriatr Cardiol       Date:  2014-09       Impact factor: 3.327

Review 7.  Advanced tracers in PET imaging of cardiovascular disease.

Authors:  Yesen Li; Wei Zhang; Hua Wu; Gang Liu
Journal:  Biomed Res Int       Date:  2014-10-15       Impact factor: 3.411

Review 8.  Mitochondrial-Targeted Molecular Imaging in Cardiac Disease.

Authors:  Jinhui Li; Jing Lu; You Zhou
Journal:  Biomed Res Int       Date:  2017-05-30       Impact factor: 3.411

9.  Diagnostic value of quantitative coronary flow reserve and myocardial blood flow estimated by dynamic 320 MDCT scanning in patients with obstructive coronary artery disease.

Authors:  Masahiko Obara; Masanao Naya; Noriko Oyama-Manabe; Tadao Aikawa; Yuuki Tomiyama; Tsukasa Sasaki; Yasuka Kikuchi; Osamu Manabe; Chietsugu Katoh; Nagara Tamaki; Hiroyuki Tsutsui
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

Review 10.  Positron Emission Tomography in the Diagnosis and Management of Coronary Artery Disease.

Authors:  Eglė Kazakauskaitė; Diana Žaliaduonytė-Pekšienė; Eglė Rumbinaitė; Justas Keršulis; Ilona Kulakienė; Renaldas Jurkevičius
Journal:  Medicina (Kaunas)       Date:  2018-07-11       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.